Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial

29 Sept 2021

Abstract excerpt

BACKGROUND: Reduction of the reservoir of latent HIV-infected cells might increase the possibility of long-term remission in individuals living with HIV. We investigated factors associated with HIV-1 proviral DNA levels in children receiving different antiretroviral therapy (ART) strategies in the children with HIV early antiretroviral therapy (CHER) trial. METHODS: Infants with HIV < 12 weeks old with CD4% ≥ 25%...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34587974
DOI: 10.1186/s12981-021-00389-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialPMID 34587974Read ↗

The CARMA Study: Early Infant Antiretroviral Therapy—Timing Impacts on Total HIV-1 DNA Quantitation 12 Years LaterSemantic proximity Read ↗

HIV ‐1 DNA decay is faster in children who initiate ART shortly after birth than laterSemantic proximity Read ↗

Early Combination Antiretroviral Therapy Limits Exposure to HIV-1 Replication and Cell-Associated HIV-1 DNA Levels in InfantsSemantic proximity Read ↗

Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected InfantsSemantic proximity Read ↗

Intact HIV DNA decays in children with and without complete viral load suppressionSemantic proximity Read ↗

Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in ChildrenSemantic proximity Read ↗

Long-term Virologic Suppression Despite Presence of Resistance-associated Mutations Among Perinatally HIV-infected Youth.Semantic proximity Read ↗

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.Semantic proximity Read ↗

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral TherapySemantic proximity Read ↗

Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)Semantic proximity Read ↗

A trial of three antiretroviral regimens in HIV-1-infected children.Semantic proximity Read ↗

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.